Scientists test new cancer Pill's hidden effects on common drugs
NCT ID NCT06899061
Summary
This early-stage study aims to understand how a new oral drug called saruparib interacts with other common medications in patients with advanced solid tumors. It will also test if different ways of making the pill affect how the body absorbs it. The main goal is to gather safety and interaction data, not to directly treat the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Sofia, 1618, Bulgaria
-
Research Site
Chisinau, MD-2025, Moldova
-
Research Site
Bucharest, 022338, Romania
-
Research Site
Cluj-Napoca, 400015, Romania
Conditions
Explore the condition pages connected to this study.